Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.3.4 and removed Revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:16:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link as well as the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:13:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page history shows a minor revision update (v3.3.2) replacing v3.3.1, a footer-level change with no impact on core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:24:18.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The history shows an addition of Revision: v3.3.1 and a deletion of Revision: v3.2.0, indicating a routine site update with no impact on trial data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:51:44.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The top banner informing users about government funding and potential delays was removed. The page now shows the record history without that informational notice.
    Difference
    0.2%
    Check dated 2025-11-17T06:27:23.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page history introduces a Recruitment Status entry in the navigation, and subsequent versions show updates to Study Status and related sections.
    Difference
    0.1%
    Check dated 2025-11-03T01:08:25.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.